Peer-to-peer insurance company Lemonade raises $120M Series C led by SoftBank, sources say at a $500M+ valuation
Lemonade had raised $60 million prior to this new round — Previous backers include Google Ventures and Sequoia Capital — SoftBank Group Corp. is betting that technology …
Context & Ripple Effects
By late 2017 Lemonade had already assembled an unusual stack for an insurance startup: a $13 million seed from Aleph and Sequoia, a New York launch where it secured a license to issue its own policies rather than rent one, and an $33.1M raise confirmed via SEC filings. The $120M Series C is the round where SoftBank takes the lead seat, valuing the company above $500M — roughly ten times its seed-stage size in two years.
What makes this round notable in hindsight is who wrote the check: SoftBank's lead position here set up both the $300M Series D it led in 2019 at a $2B+ valuation and, ultimately, the 2020 NYSE debut that closed up 140% at a $3.93B market cap. This is the middle beat of that arc.
First-order effects
- SoftBank replaces Sequoia as lead investor and becomes Lemonade's largest backer, with the $500M+ valuation more than doubling the company's paper value from its prior $60M raised across earlier rounds.
- Lemonade gains a war chest sized for geographic expansion beyond its New York renters-and-homeowners base, where its own-policy license currently confines it.
Second-order effects
- Traditional carriers and rival insurtechs now compete against an AI-distribution player with SoftBank-scale funding, pressuring them to match bot-led underwriting and pricing rather than just agent networks.
- A successful Series C at half a billion validates the peer-to-peer/AI insurance thesis for later-stage funds, priming the market for the even larger Series D that followed.
Third-order effects
- If the pattern holds, mega-fund backing compresses the insurance startup lifecycle — license, bot, blitzscale, IPO — shifting industry structure toward a small set of heavily capitalized digital carriers and leaving mid-sized insurers squeezed between legacy cost bases and venture-subsidized pricing.
The trend: Sovereign-scale funds like SoftBank are collapsing the timeline from insurtech seed round to public listing, with each oversized round setting the valuation floor for the next.